Nuclear factor κ B: A pivotal role in the systemic inflammatory response syndrome and new target for therapy

Intensive Care Medicine

Volumn 24, Issue 11, 1998, Pages 1131-1138

  Christman, J W ^a   Lancaster, L H ^a   Blackwell, T S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALPASTATIN; CORTICOSTEROID; ENDOTOXIN; ENDOTOXIN ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PHOSPHOTRANSFERASE; PROTEASOME; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

CYTOKINE RELEASE; DRUG TARGETING; HUMAN; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOLECULAR BIOLOGY; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PROTEIN PHOSPHORYLATION; RESPIRATORY DISTRESS; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL ADHESION MOLECULES; CYTOKINES; GLYCOPROTEINS; HUMANS; I-KAPPA B KINASE; INTERLEUKINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; STEROIDS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031755148     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050735     Document Type: Review

References (81)

1. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9: 2723-2735
2. Gilmore T (1991) Malignant transformation by mutant Rel proteins. Trends Genet 7: 318-322
3. Kerr LD, Verma IM (1992) Signal transduction: the nuclear target. Curr Opin Cell Biol 4: 496-501
4. Nolan GP, Baltimore D (1992) The inhibitory ankyrin and activator rel proteins. Curr. Opin. Genet.Dev. 2: 211-220
5. Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan GP, Baltimore D (1990) Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal Cell 62: 1019-1029
6. Nolan GP, Ghosh S, Liou H-C, Tempst P, Baltimore D (1991) DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64: 961-969
7. Bull P, Morley KL, Hoekstra MF, Hunter T, Verma IM (1990) The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol Cell Biol 10: 5473-5485
8. Kieran M, Blank V, Logeat F, Vandekerhove J, Lottspeoch F, Le Bail O, Urban MB, Kourilsky P, Baeuerle PA, Isreal A (1990) The DNA binding subunit of NF-κB is identical to factor KBF-1 and homologous to the rel oncogene product. Cell 62, 1007-1018
9. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequence. Cell 46, 705-716
10. Sen R, Baltimore D (1986) Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by posttranslational mechanism. Cell 47:921-929
11. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M (1997) Identification and characterization of an IκB kinase. Cell 90: 373-383
12. DiDonato JA, Hayakawa M, Rtohwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554
13. Woronicz JD, Goa X, Cao Z, Rothe M, Goeddel DV (1997) IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278: 866-869
14. Ling L, Cao Z, Goeddel (1998) NF-κB inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc Natl Acad Sci USA 95: 3792-3797
15. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW (1995) Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15: 2809-2818
16. Treanckner E B-M, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA (1995) Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14: 2876-2883
17. Huang J, Gao X, Li S, Cao Z (1997) Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 94: 12829-12832
18. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU (1997) The interleukin-1 receptor accessory protein (IL-RAcP) is essential for IL-induced activation of interleukin-receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272: 7727-7731
19. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV (1996) TRAF6 is a signal transducer for interleukin-1. Nature 83: 443-446
20. Croston GE, Cao Z, Goeddel DV (1995) NF-kappa B activation by interleukin-(IL-) requires an IL-receptor-associated protein kinase activity. J Biol Chem 270: 16514-1651
21. Blackwell TS, Holden EP, Blackwell TR, DeLarco JE, Christman JW (1994) Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor κB. Am J Respir Cell Mol Biol 11(4):464-472
22. Blackwell TS, Holden EP, Blackwell TR, Christman BW, Christman JW (1996) Activation of NF-κB in rat lungs by treatment with endotoxin: modulation by treatment with N-acetylcysteine. J Immunol 157: 1630-1637
23. Blackwell TS, Blackwell TR, Christman JW (1997) Imparied activation of NF-κB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol 158: 5934-5940
24. Haddad EB, Salmon M, Koto H, Barnes PJ, Adcock I, Chung KF (1996) Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-κ b in rat lung: inhibition by corticosteroids. FEBS Lett 379(3):265-268
25. Shenkar R, Schwartz MD, Terada LS, Repine JE, Mccord J, Abraham E (1996) Hemorrhage activates NF-κ B in murine lung mononuclear cells in vivo. Am J Physiol: Lung Cell Mol Physiol 14:L729-L735
26. Sakurai H, Hisada Y, Ueno M, Sugiura M, Kawashima K, Sugita T (1996) Activation of transcription factor NF-κ B in experimental glomerulonephritis in rats. Biochim Biophys Acta 1316: 132-138
27. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996) Local administration of antisense phosphorothiotate oligonucleotides to the p65 subunit of NF-κ B abrogates established experimental colitis in mice. Nature Medicine 2: 998-1004
28. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Ilmer T, Mannel D, Bottiger BW, Stern DM, Walderr R, Saeger H-D, Zeigler R, Bierhaus A, Martin E, Nawroth PP (1997) Role of NF-κB in the mortality of sepsis. J Clin Invest 100: 972-985
29. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E (1996) Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24: 1285-1292
30. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Ticherling M, Christophers E, Matthay MA (1992) Elevated levels of NAP-/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146: 427-432
31. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA (1991) Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144: 268-271
32. Asahara H, Asanuma M, Ogawa N, Nishibayashi S, Inoue H (1995) High DNA-binding activity of transcription factor NF-κB in synovial membranes of patients with rheumatoid arthritis. Biochem Mol Biol Intl 37: 827-832
33. Ellis RD, Limb GA, Thompson RPH, Punchard NA (1997) NF-κB in Crohn's disease. Biochem Soc Trans 178S:25
34. Lugue I, Gelinas C (1997) Rel/NF-kappa B and I kappa B factors in oncogenesis. Sem Cancer Biol 8: 103-111
35. Kitamura Y, Shimohama S, Ota T, Matsuoka Y, Nomura Y, Taniguchi T (1997) Alteration of transcrtiption factors NF-kappa B and STAT1 in Alzheimer's disease brains. Neurosci Lett 237: 17-20
36. Weikert LF, Bernard GR (1996) Pharmacotherapy of sepsis. Clin Chest Med 17(2):289-305
37. Christman JW, Holden EP, Blackwell TS (1995) Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 23: 955-963
38. Schreck RK, Alberman K, Baeuerle PA (1992) Nuclear factor κB: an oxidative stress-response transcription factor of eukaryotic cells. Free Radic Res Commun 17: 221-237
39. Mirochnitchenko O, Inouye M (1996) Effect of overexpression of human Cu,Zn superoxide dismutase in transgenic mice on macrophage functions. J Immunol 156: 1578-1586
40. Suzuki YJ, Packer L (1993) Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem Biophys Res Commun 193: 277-283
41. Erl W, Weber C, Wardemann C, Weber PC (1997) Alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol 273: H634-640
42. Offermann MK, Lin JC, Mar EC, Shaw R, Yang J, Medford RM (1996) Antioxidant-sensitive regulation of inflammatory-response genes in Kaposi's sarcoma cells. J Acqui Immune Defic Syndr Hum Retrovirol 13: 1-11
43. Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci USA 91: 1672-1676
44. Makropoulos V, Bruning T, Schulze-Osthoff K (1996) Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-LTR promoter activity. Arch Toxicol 70: 277-283
45. Harakeh S, Jariwalla RJ (1997) NF-kappa B-independent suppression of HIV expression by ascorbic acid. AIDS Res Hum Retroviruses 13: 235-239
46. Essani NA, Fisher MA, Jaeschke H (1997) Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-gene transcription, and protection against endotoxin-induced liver injury. Shock 7: 90-96
47. Geng Z, Rong Y, Lau BH (1997) S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radic Biol Med 23: 345-350
48. Suter PM, Domenighetti G, Schaller MD, Laverriere MC, Ritz R, Perret C (1994) N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 105: 190-194
49. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO (1992) Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med 20: 918-923
50. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, Wright PE (1997) A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 112: 164-172
51. Sprong RC, Winkelhuyzen-Janssen AM, Aarsman CJ, Van Oirschot JF, van der Bruggen T, van Asbeck BS (1998) Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am J Respir Crit Care Med 57: 1283-1293
52. Flohe L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L (1997) Redox regulation of NF-kappa B activation. Free Radic Biol Med 22: 1115-1126
53. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW (1995) Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci USA 92: 11259-11263
54. Whiteside ST, Ernst MK, LeBail O, Laurent-Winder C, Rice N, Israel N (1995) N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity. Mol Cell Biol 15: 5339-5345
55. Naumann M, Scheidereit C (1994) Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J 13: 4597-4607
56. Sun SC, Maggirwar SB, Harhaj E (1995) Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. J Biol Chem 270: 18347-18351
57. Mahon TM, O'Neill LA (1995) Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T-lymphocytes. Evidence for covalent modification of the p50 subunit. J Biol Chem 270: 28557-28564
58. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF (1996) Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86: 787-798
59. Singh S, Aggarwal BB (1995) Protein tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of nuclear transcription factor NF-kappa B. J Biol Chem 270: 10631-10639
60. Lee FS, Hagler J, Chen ZJ, Maniatis T (1997) Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88: 213-222
61. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A (1997) IKK and IKK-: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866
62. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M (1997) The I-kappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252
63. Natoli G, Costanzo A, Moretti F, Fulco M, Balsano C, Levrero M (1997) Tumor necrosis factor (TNF) receptor 1 signalling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J Biolog Chem 272: 26079-26082
64. Lin Y, Brown K, and Siebenlist U (1995) Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Natl Acad Sci USA 92: 552-556
65. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T (1995) Signal-induced site-specific phosphorylation targets IKBu to the ubiquitin-proteasome pathway. Genes Dev 9: 1586-1597
66. Milligan SA, Owens MW, Grisham MB (1996) Inhibition of IκB-alpha and IκB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis. Arch Biochem Biophys 335: 388-395
67. Griscavage JM, Wilk S, Ignarro LJ (1996) Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc Natl Acad Sci USA 93: 3308-3312
68. Schow SR, Joly A (1997) N-acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysaccharide-induced NF-κB activation and prevents TNF and IL-6 synthesis in vivo. Cell Immunol 175: 199-202
69. Reutten H, and Thiemermann C (1997) Effect of calpain inhibitor I. an inhibitor of the proteolysis of IκB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol 121: 695-704
70. Ciechanover A (1994) The ubiquitin-proteasome pathway. Cell 79: 13-21
71. Haddad EB, Salmon M, Koto H, Barnes PJ, Adcock I, Chung KF (1996) Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-kappa b in rat lung: inhibition by corlicosteroids. FEBS Lett 379: 265-268
72. Ray A, KE Prefontaine (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91: 752-756
73. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995) Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270: 283-286
74. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270: 286-290
75. Zuckerman SH, Evans GF (1992) Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol 140: 513-519
76. Blackwell TS, Blackwell TR, Christman JW (1997) Impaired activation of NF-κB in endotoxin tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol 158: 5934-5940
77. Blackwell TS, Blackwell TR, Christman JW (1997) Endotoxin tolerance is associated with depletion of RelA and increased formation of p50 homodimers in rat alveolar macrophages. J Leukoc Biol 62: 885-891
78. Ziegler-Heitbrock HWL, Wedel A, Schraut W, Strobel M, Wedelgass P, Sternsdorf T, Bauerle P, Haas JG, Riethmuller G (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269: 17001-17004
79. Carpati CM, Astiz ME, Rachow EC, Kim JW, Kim YB, Weil MH (1992) Monophophoryl Lipid A attenuates the effect of endotoxin shock in pigs. J Lab Clin Med 119: 346-353
80. Astiz ME, Saha DC, Brooks K, Carpati CM Rackow EC (1993) Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl Lipid A and lipopolysaccharide. Circ Shock 39: 194-198
81. Astiz ME, Rackow EC, Still JG, Howell ST, Cato A, Von Eschen KB, Ulrich JT, Rudbach JA, McMahon G, Vargas R (1995) Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med 23: 9-17